Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer

被引：0
|
作者：
Valiente, Consolacion Molto [1 ,2 ]
Amir, Eitan [1 ,2 ,3 ,4 ]
机构：
[1] Princess Margaret Canc Ctr, Dept Med, Div Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Princess Margaret Canc Ctr, Dept Med, Div Med Oncol & Hematol, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, 610 Univ Ave, Toronto, ON M5G 2M9, Canada
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 07期
关键词：
Metastatic breast cancer; triple negative; PARP inhibitors; BRCAness; BRCA-like phenotype; AMERICAN SOCIETY; CLINICAL BENEFIT; DOUBLE-BLIND; FRAMEWORK; OLAPARIB; MAGNITUDE; VELIPARIB; MUTATION; PLACEBO; PHASE-2;
D O I：
10.21037/tcr-23-365
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1887 / 1890
页数：4
相关论文
共 50 条
  • [1] Chemotherapy of metastatic triple negative breast cancer: Experience of using platinum-based chemotherapy
    Zhang, Jian
    Fan, Minhao
    Xie, Jie
    Wang, Zhonghua
    Wang, Biyun
    Zhang, Sheng
    Wang, Leiping
    Cao, Jun
    Tao, Zhonghua
    Li, Ting
    Hu, Xichun
    ONCOTARGET, 2015, 6 (40) : 43135 - 43143
  • [2] Platinum-based chemotherapy in triple negative breast cancer
    Eckstein, N.
    Haas, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (07) : 333 - 336
  • [3] Platinum-based chemotherapy in triple-negative breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    ANNALS OF ONCOLOGY, 2008, 19 (11) : 1847 - 1852
  • [4] Platinum-Based Chemotherapy in Triple-Negative Breast Cancer
    Villarreal-Garza, C.
    Bouganim, N.
    Khalaf, D.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J.
    Dent, R.
    CANCER RESEARCH, 2011, 71
  • [5] Platinum-based chemotherapy in triple-negative breast cancer
    Villarreal-Garza, C. M.
    Clemons, M.
    Kassam, F.
    Enright, K.
    Verma, S.
    Myers, J. A.
    Dent, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience
    Staudacher, L.
    Cottu, P. H.
    Dieras, V.
    Vincent-Salomon, A.
    Guilhaume, M. N.
    Escalup, L.
    Dorval, T.
    Beuzeboc, P.
    Mignot, L.
    Pierga, J. Y.
    ANNALS OF ONCOLOGY, 2011, 22 (04) : 848 - 856
  • [7] Platinum-based chemotherapy in triple-negative (TN) breast cancer
    Sirohi, B.
    Arnedos, M.
    Popat, S.
    Ashley, S.
    Nerurkar, A.
    Walsh, G.
    Johnston, S.
    Smith, I. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Platinum-based chemotherapy for early triple-negative breast cancer
    Mason, Sofia R. E.
    Willsons, Melina L.
    Egger, Sam J.
    Beith, Jane
    Dear, Rachel F.
    Goodwin, Annabel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (09):
  • [9] Platinum-based chemotherapy in triple-negative advanced breast cancer
    Villarreal-Garza, Cynthia
    Khalaf, Daniel
    Bouganim, Nathaniel
    Clemons, Mark
    Pena-Curiel, Omar
    Baez-Revueltas, Berenice
    Kiss, Alexander
    Kassam, Farah
    Enright, Katherine
    Verma, Sunil
    Pritchard, Kathleen
    Myers, Jeff
    Dent, Rebecca
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 146 (03) : 567 - 572
  • [10] Platinum-based chemotherapy in triple-negative advanced breast cancer
    Cynthia Villarreal-Garza
    Daniel Khalaf
    Nathaniel Bouganim
    Mark Clemons
    Omar Peña-Curiel
    Berenice Baez-Revueltas
    Alexander Kiss
    Farah Kassam
    Katherine Enright
    Sunil Verma
    Kathleen Pritchard
    Jeff Myers
    Rebecca Dent
    Breast Cancer Research and Treatment, 2014, 146 : 567 - 572
12345